We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sign up to read this article for FREE!

After signing up, you'll start to receive regular news updates from us.

Halo Genomics and Uppsala University to Colloborate

News  
Published: November 9, 2011 
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above. ✖

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

By submitting your email address, you agree to receive email communications related to Technology Networks content, products, or our partners. You may unsubscribe from these communications at any time as we respect your privacy. View our Privacy Policy for more information.
Read time: Less than a minute

The aim of the study is to provide better diagnostic tools for individualized cancer treatment. Using HaloPlex PCR, the researchers were able to analyze a large number of samples in record time. The results show that HaloPlex PCR technology is useful for so-called companion diagnostics, as required to select the optimal cancer treatment.

Related Topic Pages
PCR
Anticancer Therapies
Advertisement
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter